Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Eden Research ( (GB:EDEN) ).
Eden Research plc has appointed Syngenta Crop Protection AG as its exclusive distribution partner for its novel fungicide product Evelta™, targeting the professional ornamental crop market in multiple EU countries and the UK. This collaboration marks Eden’s first commercial agreement with one of the world’s largest crop protection companies, aligning with its goal of expanding its market reach and reinforcing its commitment to delivering sustainable solutions to growers while enhancing operational execution and stakeholder value.
The most recent analyst rating on (GB:EDEN) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Eden Research stock, see the GB:EDEN Stock Forecast page.
Spark’s Take on GB:EDEN Stock
According to Spark, TipRanks’ AI Analyst, GB:EDEN is a Neutral.
Eden Research’s score is driven by its financial challenges and bearish technical indicators. However, recent corporate events, including product approvals and insider buying, provide positive signals for future growth potential.
To see Spark’s full report on GB:EDEN stock, click here.
More about Eden Research
Eden Research plc is a leader in sustainable biopesticides and biocontrol technology, focused on developing innovative solutions for the agricultural industry. The company specializes in environmentally friendly fungicides and works with global partners to enhance market accessibility and promote sustainable practices.
Average Trading Volume: 323,142
Technical Sentiment Signal: Sell
Current Market Cap: £12.8M
Find detailed analytics on EDEN stock on TipRanks’ Stock Analysis page.